These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 25367940)

  • 1. RBM4-regulated alternative splicing suppresses tumorigenesis.
    Cancer Discov; 2014 Nov; 4(11):1253. PubMed ID: 25367940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.
    Wang Y; Chen D; Qian H; Tsai YS; Shao S; Liu Q; Dominguez D; Wang Z
    Cancer Cell; 2014 Sep; 26(3):374-389. PubMed ID: 25203323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism.
    Chang HL; Lin JC
    Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118550. PubMed ID: 31491447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of RNA binding motif protein 4-regulated splicing cascade on the progression and metabolism of colorectal cancer cells.
    Liang YC; Lin WC; Lin YJ; Lin JC
    Oncotarget; 2015 Nov; 6(35):38046-60. PubMed ID: 26506517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RBM4 modulates the proliferation and expression of inflammatory factors via the alternative splicing of regulatory factors in HeLa cells.
    Wang WY; Quan W; Yang F; Wei YX; Chen JJ; Yu H; Xie J; Zhang Y; Li ZF
    Mol Genet Genomics; 2020 Jan; 295(1):95-106. PubMed ID: 31489484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer.
    Lv Y; Zhang W; Zhao J; Sun B; Qi Y; Ji H; Chen C; Zhang J; Sheng J; Wang T; Dominguez D; Liu H; Liu Q; Meng S; Li X; Wang Y
    Signal Transduct Target Ther; 2021 Mar; 6(1):108. PubMed ID: 33664238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional pre- mRNA trans-splicing of coactivator CoAA and corepressor RBM4 during stem/progenitor cell differentiation.
    Brooks YS; Wang G; Yang Z; Smith KK; Bieberich E; Ko L
    J Biol Chem; 2009 Jul; 284(27):18033-46. PubMed ID: 19416963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer.
    de Miguel FJ; Pajares MJ; Martínez-Terroba E; Ajona D; Morales X; Sharma RD; Pardo FJ; Rouzaut A; Rubio A; Montuenga LM; Pio R
    Mol Oncol; 2016 Nov; 10(9):1437-1449. PubMed ID: 27555542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective regression of cancer cells expressing a splicing variant of AIMP2 through targeted RNA replacement by trans-splicing ribozyme.
    Won YS; Lee SW
    J Biotechnol; 2012 Mar; 158(1-2):44-9. PubMed ID: 22285955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo.
    Markus MA; Heinrich B; Raitskin O; Adams DJ; Mangs H; Goy C; Ladomery M; Sperling R; Stamm S; Morris BJ
    Exp Cell Res; 2006 Oct; 312(17):3379-88. PubMed ID: 16934801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RNA-binding protein QKI suppresses cancer-associated aberrant splicing.
    Zong FY; Fu X; Wei WJ; Luo YG; Heiner M; Cao LJ; Fang Z; Fang R; Lu D; Ji H; Hui J
    PLoS Genet; 2014 Apr; 10(4):e1004289. PubMed ID: 24722255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
    Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP
    Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-binding protein CELF6 modulates transcription and splicing levels of genes associated with tumorigenesis in lung cancer A549 cells.
    Ma H; Liu G; Yu B; Wang J; Qi Y; Kou Y; Hu Y; Wang S; Wang F; Chen D
    PeerJ; 2022; 10():e13800. PubMed ID: 35910766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of SAMD9 suppresses tumorigenesis and progression during non small cell lung cancer.
    Ma Q; Yu T; Ren YY; Gong T; Zhong DS
    Biochem Biophys Res Commun; 2014 Nov; 454(1):157-61. PubMed ID: 25450373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splicing factor poly(rC)-binding protein 1 is a novel and distinctive tumor suppressor.
    Guo J; Jia R
    J Cell Physiol; 2018 Jan; 234(1):33-41. PubMed ID: 30132844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear Aurora kinase A switches m
    Li S; Qi Y; Yu J; Hao Y; He B; Zhang M; Dai Z; Jiang T; Li S; Huang F; Chen N; Wang J; Yang M; Liang D; An F; Zhao J; Fan W; Pan Y; Deng Z; Luo Y; Guo T; Peng F; Hou Z; Wang C; Zheng F; Xu L; Xu J; Wen Q; Jin B; Wang Y; Liu Q
    Signal Transduct Target Ther; 2022 Apr; 7(1):97. PubMed ID: 35361747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RBM4 regulates cellular senescence via miR1244/SERPINE1 axis.
    Wang L; Zhang X; Sheng J; Chen L; Zhi L; Zheng Q; Qi Y; Wang L; Zhang J; Zhao J; Wang Y; Liu SX; Sun MZ; Zhang W
    Cell Death Dis; 2023 Jan; 14(1):27. PubMed ID: 36639375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression.
    Ezponda T; Pajares MJ; Agorreta J; Echeveste JI; López-Picazo JM; Torre W; Pio R; Montuenga LM
    Clin Cancer Res; 2010 Aug; 16(16):4113-25. PubMed ID: 20682707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell stress modulates the function of splicing regulatory protein RBM4 in translation control.
    Lin JC; Hsu M; Tarn WY
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2235-40. PubMed ID: 17284590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha CP-4, encoded by a putative tumor suppressor gene at 3p21, but not its alternative splice variant alpha CP-4a, is underexpressed in lung cancer.
    Pio R; Zudaire I; Pino I; Castaño Z; Zabalegui N; Vicent S; Garcia-Amigot F; Odero MD; Lozano MD; Garcia-Foncillas J; Calasanz MJ; Montuenga LM
    Cancer Res; 2004 Jun; 64(12):4171-9. PubMed ID: 15205328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.